NCOUNTER SPRINT

Serial Number 86357017
Registration 5124745
702

Registration Progress

Application Filed
Aug 4, 2014
Under Examination
Nov 17, 2015
Approved for Publication
Sep 22, 2015
Published for Opposition
Sep 22, 2015
Registered
Jan 17, 2017

Trademark Image

NCOUNTER SPRINT

Basic Information

Serial Number
86357017
Registration Number
5124745
Filing Date
August 4, 2014
Registration Date
January 17, 2017
Published for Opposition
September 22, 2015
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Jun 29, 2022
Registration
Registered
Classes
001 005 009

Rights Holder

BRUKER SPATIAL BIOLOGY, INC.

03
Address
40 MANNING ROAD
BILLERICA, MA 01821

Ownership History

NanoString Technologies, Inc.

Original Applicant
03
Seattle, WA

NanoString Technologies, Inc.

Owner at Publication
03
Seattle, WA

NanoString Technologies, Inc.

Original Registrant
03
Seattle, WA

BRUKER SPATIAL BIOLOGY, INC.

New Owner After Registration #1
03
BILLERICA, MA

Legal Representation

Attorney
Alyssa M. Worsham

USPTO Deadlines

Next Deadline
3999 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Extended from 2027-01-17)
Due Date
January 17, 2037
Grace Period Ends
July 17, 2037

Application History

46 events
Date Code Type Description Documents
Jan 29, 2026 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Jan 17, 2026 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jul 4, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jun 29, 2022 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jun 29, 2022 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jun 29, 2022 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 25, 2022 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jan 17, 2022 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Mar 18, 2020 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jan 17, 2017 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 13, 2016 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 12, 2016 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Nov 18, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 17, 2016 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Nov 7, 2016 IUAF S USE AMENDMENT FILED Loading...
Nov 17, 2016 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 7, 2016 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 7, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 7, 2016 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 10, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 9, 2016 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 13, 2016 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 9, 2016 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 13, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 17, 2015 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 22, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 22, 2015 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 2, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 19, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Aug 12, 2015 ALIE A ASSIGNED TO LIE Loading...
Jul 29, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 12, 2015 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Jul 11, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 10, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 10, 2015 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 10, 2015 PETG O PETITION TO REVIVE-GRANTED Loading...
Jul 10, 2015 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Jun 22, 2015 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Jun 22, 2015 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Nov 24, 2014 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 24, 2014 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 24, 2014 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 17, 2014 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 14, 2014 MPMK E NOTICE OF PSEUDO MARK E-MAILED Loading...
Aug 13, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 7, 2014 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors, namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing
First Use Anywhere: 20150900
First Use in Commerce: 20150900
Class 005
diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising reagents for medical use; medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care, namely, medical diagnostic reagents and diagnostic reagents for clinical or medical laboratory use, diagnostic reagents for medical in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis comprised of reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes
First Use Anywhere: 20150900
First Use in Commerce: 20150900
Class 009
computer-based apparatus for detection and analysis of gene expression for scientific use; computer-based apparatus for scientific research, namely, for collecting, processing, and taking images of data in connection with scientific or medical research, the use of diagnostic preparations and reagents for scientific or research use, RNA transcription and microRNA expression profiling, proteomics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, analysis of functional pathway gene sets, and monitoring of biofuel production, and prognostic, predictive, clinical, oncology, and hematology diagnostics; scientific research equipment for imaging single molecule reporters; scanning microscopes; fluorescent microscopes; laboratory equipment, namely, fluidics stations, hybridisation ovens, cartridges carriers and replacement parts therefor; scientific research instruments to process and analyze the single molecule reporters to manage and obtain information from the single molecule reporters; computer software to acquire, analyze and manage the biologic data generated; computer software for controlling fluidics station and scanner functions, for capturing fluorescent signals, and for extracting and analyzing data; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices; kits for scientific research use, namely, for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples, detecting the presence of analytes in samples and identifying sample types; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices, reports, test results, research material, worksheets and other non-printed documents and publications, all being downloadable
First Use Anywhere: 20150600
First Use in Commerce: 20150600

Additional Information

Pseudo Mark
ENCOUNTER SPRINT

Classification

International Classes
001 005 009